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Ultimately, we somehow managed to end up with something
that looked reasonably pure, and we sent an unsettlingly large
portion of sample to Phil Andrews at Purdue University for
amino acid sequence analysis. At this point, one of us was
more than a little nervous—after all, John hadn’t graduated
yet. One afternoon John came back from lunch, and there
was a small piece of folded yellow paper on his desk. John
was told that it was a message from Phil and that he would
know what it meant. Indeed, that was the case when he opened
the note and all it said was DPKQDFMRFH2. It was the amino
acid sequence of the fly FMRFamide neuropeptide. Analysis
of cDNA clones led to the determination that the Drosophila
FMRFamide precursor is also quite complex, as it contained
five complete copies of DPKQDFMRFamide as well as ten re-
lated peptides. In an amazing example of synchronicity, Paul
Taghert’s laboratory at Washington University had simulta-
neously identified the Drosophila FMRFamide gene. Both Ri-
chard and Paul’s lab went on to explore the function and regu-
lation of this gene, and since then, many other neuropeptides
and their receptors have been characterized using Drosophila
molecular genetics. Indeed, such studies will be among the
topics at an upcoming meeting on Insect Neuromodulators
and Neuropeptides at Janelia Farms.
In deciding where to submit our manuscript on Drosophila
FMRFamide, Richard noted that a brand new journal, Neuron,
was going to be published by Cell Press and focus on cellular
and molecular neurobiology. This presented a wonderful oppor-
tunity, and our work was published in the inaugural issue of
Neuron in March 1988. Over the last 20 years, Neuron has grown
to be the premier journal in neurobiology and published many of
the most important and influential papers in neuroscience.
Today, John is a tenured professor with his own lab, and Ri-
chard is Executive Vice President for Research and Chief Scien-
tific Officer at Genentech. Our lives have changed considerably
since the first issue of Neuron, but we will always be friends, hav-
ing shared the excitement and joy of scientific discovery.
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Brain type II Ca2+/calmodulin-dependent protein kinase is a holoenzymecomposed of several copies each
of three subunits, a (50 kd), b (60 kd), and b0 (58 kd), in varying proportions. The deduced amino acid
sequences of a (reported here) and b are highly similar but not identical. The major difference between
them is the deletion from a of two short segments (residues 316–339 and 354–392 in b). cDNAs that
appear to encode b0 are identical to b except for the deletion of a segment encoding residues 378–392.
Thus, the structural differences among a, b, and b0 arise primarily from deletions (or insertions) in
a variable region lying immediately carboxyl to the protein kinase and calmodulin-binding domains. The
a and b subunits are encoded by distinct genes expressed primarily, if not exclusively, in brain. Rather
than being encoded by a third gene, b0 may arise by alternative splicing of the b gene transcript.In the two decades after the founding of Neuron, we witnessed
the unfolding of the ‘‘molecular biology revolution’’ and its culmi-
nation in the sequencing of individual genomes. Cloning of
cDNAs and rapid nucleotide sequencing were invented in the
early 1970s. By the mid-1980s, ‘‘cDNA-cloning’’ was all therage. A new breed of ‘‘molecular neuroscientists’’ began cloning
and sequencing transcripts encoding neuronal receptors, ion
channels, and signaling enzymes. The wealth of molecular data
they generated set the stage for rigorous study of neuronal cell
biology.Neuron 60, November 6, 2008 ª2008 Elsevier Inc. 401
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only, way to learn the primary sequence of a protein. Our paper
in the inaugural issue of Neuron reported the first comparison of
the primary sequences and domain structures of the a and b sub-
units of brain calcium/calmodulin-dependent protein kinase II
(CaMKII). The study was completed at a time when interest in the
role of CaMKII at synapses was growing rapidly, although its pre-
cise role was still undefined. We had purified CaMKII from brain
in 1983 (Bennett et al., J. Biol. Chem. 258, 12735–12744, 1983)
and shown by well-established biochemical methods that it is a
large holoenzyme composed of twelve subunits, nine 50 kD sub-
units (on average) that we termed a subunits, and three 60 kD
subunits termed b subunits. In the same year, we reported that
the a subunit was a major constituent of the ‘‘postsynaptic den-
sity’’ fraction, a subcellular organelle associated with the post-
synaptic membrane of glutamatergic synapses (Kennedy et al.,
Proc. Natl. Acad. Sci. USA 80, 7357–7361, 1983). We measured
the amount of CaMKII in various brain regions and found that it
constitutes 1% of total protein in the forebrain, a surprisingly
high number for a signaling enzyme (Erondu and Kennedy, J.
Neurosci. 5, 3270–3277, 1985). Then, in 1986, we reported that
activation of CaMKII worked like a switch in which autophos-
phorylation of sites in CaMKII itself caused it to remain active,
even in the absence of calcium (Miller and Kennedy, Cell 44,
861–870, 1986). All of these results pointed toward an important
function for CaMKII at synapses.
When the paper by Bulleit et al. was written, the field had
just begun to understand how to extract information about a pro-
tein’s function from its primary sequence. Canonical functional
domains comprising conserved sequence motifs were being
defined, as were consensus substrate phosphorylation sites for
members of the growing protein kinase family. The individual
sequences of the b (Bennett and Kennedy, Proc. Natl. Acad.
Sci. USA 84, 1794–1798, 1987) and a subunits (Lin et al., Proc.
Natl. Acad. Sci. USA 84, 5962–5966, 1987) had been published
a few months prior to this study, revealing that both subunits
contained protein kinase catalytic domains followed by a canon-
ical calmodulin-binding site; however, the sequences of the
two subunits had not been thoroughly compared. Our paper es-
tablished the basic domain structure of subunits of CaMKII and
showed where insertion of new sequences created the greatest
differences among them. We pointed out two conserved con-
sensus phosphorylation sites, one of which, threonine-286,
was later shown to be the autophosphorylation site that main-
tains calcium-independent activity (Hanson et al., Neuron 3,
59–70, 1989; Miller et al., Neuron 1, 593–604, 1988; Schworer
et al., J. Biol. Chem. 263, 13486–13489, 1988; Thiel et al., Proc.
Natl. Acad. Sci. USA 85, 6337–6341, 1988).
These intriguing biochemical studies of CaMKII led molecular
biologist Alcino Silva to undertake deletion of the a subunit from
mice by homologous recombination, at that time a very new and
still tricky technique. The phenotype of his aCaMKII knockout
mouse established that CaMKII is indeed critical for normal
long-term potentiation and hippocampal-dependent learning
(Silva et al., Science 257, 206–211, 1992a; Silva et al., Science
257, 201–206, 1992b). More recently, the Kuriyan laboratory
(Rosenberg et al., Cell 123, 849–860, 2005) and others (Kolodziej
et al., J. Biol. Chem. 275, 14354–1435, 2000; Morris and Torok,402 Neuron 60, November 6, 2008 ª2008 Elsevier Inc.J. Mol. Biol. 308, 1–8, 2001) have applied elegant protein struc-
tural analyses to define, at atomic resolution, the arrangement of
subunits in the dodecameric CaMKII holoenzyme and the struc-
tural transitions that occur when they are activated. A host of
studies have begun to clarify how CaMKII exerts its regulatory
effects on synaptic plasticity. The difficulty of this task is a testa-
ment to the complexity of the biochemical pathways that regu-
late synaptic plasticity in the central nervous system.
Are there new techniques and approaches on the horizon that
will allow us to see more clearly into the workings of CaMKII and
the machinery of synaptic plasticity? There are many. Here are
two of my favorites:
d Submicron-resolution microscopy. New microscopy tech-
niques, including cryo-electron microscopy (Lucic et al.,
Annu. Rev. Biom. 74, 833–865, 2005) and fluorescence pho-
toactivation localization microscopy (FPALM) (Juette et al.,
Nat. Methods 5, 527–529, 2008), enable resolution of struc-
tures at 10 nm over depths of several microns in tissue.
They offer the hope that we will soon be able to discern the
structure of macromolecular machinery in the synapse and
followthedynamicsof individualmacromolecularcomplexes
as they respond to stimuli and carry out their functions.
d Virtual reconstitution experiments. The flow of information
through a regulatory network involves changes in activities
of interlocking cascades of enzymes. A signal, such as
massive activation of NMDA receptors in a spine, first tran-
siently shifts the activities of a series of enzymes. At some
point, the activity of each enzyme settles into a new steady
state. Classically, biochemists attempted to test their un-
derstanding of multienzyme processes by reconstituting
them in a test tube from purified components. However,
regulatory networks in synapses are exceedingly complex,
incorporating feedback loops and modulatory branches.
New computational methods, and the rapid growth of
computer power, now permit ‘‘virtual reconstitution exper-
iments.’’ The kinetic fluctuations and steady-state activity
of complex reaction pathways can be simulated in detail.
One can even place appropriate numbers of individual
proteins in a realistic spatial context and model their inter-
actions stochastically (Kerr et al., J. Sci. Comput. 30,
3126–3149, 2008). When combined with experimental
measurements of the necessary parameters (e.g., associ-
ation and dissociation rates, enzymatic turnover numbers),
computer simulations will permit precise predictions about
the workings of synaptic regulatory machinery that can be
tested experimentally. Simulations will increasingly be
used to guide the design and interpretation of experiments
probing synaptic mechanisms.
Twenty years ago, we had just begun to discover individual
molecular players at the synapse. The next decade will be spent
learning the intimate details of their repertoires.
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